Farid Ramy's Form 4 filing
Structure Therapeutics Inc.GPCR · filed Feb 9, 2023
- Accession no.
- 0001209191-23-008166
- Filed
- Feb 9, 2023
- Trade date
- Feb 7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Farid RamyCIK 0001797707 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2023 | Ordinary Shares | CConversionAcquired | +642,245 | –F1 | – | 3,260,495 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2023 | Ordinary Shares | CConversionDisposed | −642,245 | –F1 | – | 0 | Indirect | |
| Feb 7, 2023 | Ordinary Shares | PPurchaseAcquired | +825,000 | $15.00 | +$4,125,000 | 275,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
All outstanding Preferred Shares automatically converted into Ordinary Shares immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.